Company intelligence / Profile preview

Dt&CRO

Ownership: Private
Development stage: Other

Overview

Dt&CRO does not have its own clinical results or pipeline. It provides comprehensive preclinical and clinical trial services—including laboratory testing and regulatory consulting—for pharmaceutical, biotech, medical device, cosmetics, and health-functional food companies. The company has expanded capabilities in bioanalysis and efficacy evaluation centers and offers GLP/non-GLP studies[2][5].

Modalities: Small moleculeBiologicMonoclonal antibodyBiosimilarMedical device
Industry: Contract Research Organization

Partnerships

Radyus Research—strategic partnership to help South Korean biotechs enter the US market by providing integrated drug development planning/regulatory support in the US while offering Radyus access to Asian lab testing resourcesAVANCE CLINICAL—MOU signed June 2023 for collaboration on clinical trials

Beyond the preview

Go deeper on Dt&CRO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dt&CRO.

Explore the full profile